These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26779164)

  • 1. Inflammatory Biomarkers Associated with Lethal Rift Valley Fever Encephalitis in the Lewis Rat Model.
    Caroline AL; Kujawa MR; Oury TD; Reed DS; Hartman AL
    Front Microbiol; 2015; 6():1509. PubMed ID: 26779164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral Blood Biomarkers of Disease Outcome in a Monkey Model of Rift Valley Fever Encephalitis.
    Wonderlich ER; Caroline AL; McMillen CM; Walters AW; Reed DS; Barratt-Boyes SM; Hartman AL
    J Virol; 2018 Feb; 92(3):. PubMed ID: 29118127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease.
    Bird BH; Albariño CG; Nichol ST
    Virology; 2007 May; 362(1):10-5. PubMed ID: 17412386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic diversity of collaborative cross mice enables identification of novel rift valley fever virus encephalitis model.
    Cartwright HN; Barbeau DJ; Doyle JD; Klein E; Heise MT; Ferris MT; McElroy AK
    PLoS Pathog; 2022 Jul; 18(7):e1010649. PubMed ID: 35834486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choice of inbred rat strain impacts lethality and disease course after respiratory infection with Rift Valley Fever Virus.
    Bales JM; Powell DS; Bethel LM; Reed DS; Hartman AL
    Front Cell Infect Microbiol; 2012; 2():105. PubMed ID: 22919694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of inflammatory cytokines in Rift Valley fever patients are indicative of severe disease.
    Jansen van Vuren P; Shalekoff S; Grobbelaar AA; Archer BN; Thomas J; Tiemessen CT; Paweska JT
    Virol J; 2015 Oct; 12():159. PubMed ID: 26437779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.
    Ikegami T; Hill TE; Smith JK; Zhang L; Juelich TL; Gong B; Slack OA; Ly HJ; Lokugamage N; Freiberg AN
    J Virol; 2015 Jul; 89(14):7262-76. PubMed ID: 25948740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethal inhalational Rift Valley Fever.
    Caroline AL; Powell DS; Bethel LM; Oury TD; Reed DS; Hartman AL
    PLoS Negl Trop Dis; 2014 Apr; 8(4):e2790. PubMed ID: 24722586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular permeability in the brain is a late pathogenic event during Rift Valley fever virus encephalitis in rats.
    Walters AW; Kujawa MR; Albe JR; Reed DS; Klimstra WB; Hartman AL
    Virology; 2019 Jan; 526():173-179. PubMed ID: 30396029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Rift Valley fever virus infection induces inflammatory cytokines and cell death in
    Connors KA; Frey ZD; Demers MJ; Wills ZP; Hartman AL
    J Gen Virol; 2024 Mar; 105(3):. PubMed ID: 38546100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rift Valley Fever Virus Infection Causes Acute Encephalitis in the Ferret.
    Barbeau DJ; Albe JR; Nambulli S; Tilston-Lunel NL; Hartman AL; Lakdawala SS; Klein E; Duprex WP; McElroy AK
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33115835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.
    Ikegami T
    Expert Rev Vaccines; 2017 Jun; 16(6):601-611. PubMed ID: 28425834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
    Terasaki K; Tercero BR; Makino S
    Virus Res; 2016 May; 216():55-65. PubMed ID: 26022573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogenesis of Rift Valley fever virus in the mouse model.
    Smith DR; Steele KE; Shamblin J; Honko A; Johnson J; Reed C; Kennedy M; Chapman JL; Hensley LE
    Virology; 2010 Nov; 407(2):256-67. PubMed ID: 20850165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4 T Cells, CD8 T Cells, and Monocytes Coordinate To Prevent Rift Valley Fever Virus Encephalitis.
    Harmon JR; Spengler JR; Coleman-McCray JD; Nichol ST; Spiropoulou CF; McElroy AK
    J Virol; 2018 Dec; 92(24):. PubMed ID: 30258000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidate vaccines for human Rift Valley fever.
    Ikegami T
    Expert Opin Biol Ther; 2019 Dec; 19(12):1333-1342. PubMed ID: 31478397
    [No Abstract]   [Full Text] [Related]  

  • 17. Aerosolized rift valley fever virus causes fatal encephalitis in african green monkeys and common marmosets.
    Hartman AL; Powell DS; Bethel LM; Caroline AL; Schmid RJ; Oury T; Reed DS
    J Virol; 2014 Feb; 88(4):2235-45. PubMed ID: 24335307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rift Valley Fever Virus Is Lethal in Different Inbred Mouse Strains Independent of Sex.
    Cartwright HN; Barbeau DJ; McElroy AK
    Front Microbiol; 2020; 11():1962. PubMed ID: 32973712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.
    Ly HJ; Lokugamage N; Nishiyama S; Ikegami T
    PLoS One; 2017; 12(9):e0185194. PubMed ID: 28926632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and evaluation of antivirals for Rift Valley fever virus.
    Lang Y; Li Y; Jasperson D; Henningson J; Lee J; Ma J; Li Y; Duff M; Liu H; Bai D; McVey S; Richt JA; Ikegami T; Wilson WC; Ma W
    Vet Microbiol; 2019 Mar; 230():110-116. PubMed ID: 30827375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.